VC-backed STORM Therapeutics appoints Nobel Prize winner as scientific adviser
UK-based STORM Therapeutics, a developer of small molecule inhibitors of RNA-modifying enzymes to treat cancer, has named Thomas Cech as a scientific adviser. Cech, who won the Nobel Prize in Chemistry in 1989, is a professor of chemistry and biochemistry at University of Colorado, Boulder and a director of the University of Colorado BioFrontiers Institute. STORM is backed by Cambridge Innovation Capital, Merck Ventures, Pfizer Ventures, Touchstone Innovations and Taiho Ventures LLC.
29 January 2018•3 mins read
